Publications for Mark Gillies

2021 Nguyen, V., Puzo, M., Sanchez-Monroy, J., Gabrielle, P., Sheth, J., Gopal, L., Gillies, M., Khatri, M., Kuppermann, B., Garcher, C., Baudin, F., Wolff, B., Castelnovo, L., Michel, G., Roy, R., Chawla, S., Rajendran, A., Narayanan, R. (2021). O'Toole, L., Barthelmes, D., Gillies, M. (2021). Vitreoretinal Society of India practice pattern survey 2020: ASSOCIATION BETWEEN ANATOMICAL AND Medical . Indian Journal of , 69(6), 1430- CLINICAL OUTCOMES OF NEOVASCULAR AGE- 1439. [More ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR. Information] Retina, 41(7), 1446-1454. [Mor 2020 e Information] Ang, J., Ah-Moye, S., Kim, L., Nguyen, V., Hunt, A., Salem, W., Zagora, S., Nguyen, V., Mehta, H., Gillies, M., Barthelmes, D., Gillies, M., Mehta, H. (2020). A systematic Fraser-Bell, S. (2021). Effect of intravitreal injection speed on review of real-world evidence of the management of macular acute rise in intraocular pressure. The SPEED IOP study. oedema secondary to branch retinal vein occlusion. Eye, 34(10), Clinical and Experimental Ophthalmology, 49(5), 519-521. [More 0861-9">[More Information] Information] Gibson, A., Humphries, J., Gillies, M., Nassar, N., Colagiuri, S. Cornish, E., Teo, K., Nguyen, V., Squirrel, D., Gillies, M., (2020). Adherence to eye examination guidelines among Barthelmes, D. (2021). FIVE-YEAR INCIDENCE AND individuals with : An analysis of linked health data. VISUAL ACUITY OUTCOMES FOR INTRAVITREAL Clinical and Experimental Ophthalmology, 48(9), 1229-1238. IN BILATERAL NEOVASCULAR AGE- [More RELATED : Fight Retinal Information] Blindness! Project. Retina, 41(1), 118-124. [Mor Arnold, J., Young, S., Barthelmes, D., Gillies, M. (2020). e Information] Assessing The Accuracy Of A Large Observational Registry Of Zhang, R., Engel, A., Wang, Y., Li, B., Shen, W., Gillies, M., Neovascular Age-Related Macular Degeneration. Retina, 40(5), Chao, J., Du, J. (2021). Inhibition of Mitochondrial Respiration 866-872. [Mor Human Retinal Pigment Epithelium. Journal of Proteome e Information] Research, 20(1), 909-922. [More Fraser-Bell, S., Mehta, H., Gillies, M., Barthelmes, D. (2020). Information] Changes in real-world treatment patterns for diabetic macular Cornish, E., Nguyen, V., Young, S., Fraser-Bell, S., Guymer, oedema from 2009 to 2019 and 5-year outcomes: Data from the R., Squirrell, D., Barthelmes, D., Gillies, M. (2021). Fight Retinal Blindness! Registry. Clinical and Experimental Neovascular age-related macular degeneration at treatment Ophthalmology, 48(6), 802-812. [More Ophthalmology, 49(6), 570-578. href="http://dx.doi.org/10.1111/ceo.13962">[More Chong Teo, K., Saxena, N., Gan, A., Wong, T., Gillies, M., Information] Chakravarthy, U., Cheung, C. (2020). Detrimental Effect of Invernizzi, A., Parrulli, S., Monteduro, D., Cereda, M., Nguyen, Delayed Re-treatment of Active Disease on Outcomes in V., Staurenghi, G., Cheung, C., Gillies, M., Teo, K. (2021). Neovascular Age-Related Macular Degeneration: The RAMPS Outer Retinal Layer Thickening Predicts the Onset of Exudative Study. Ophthalmology Retina, 4(9), 871-880. [More Journal of Ophthalmology, 231, 19-27. href="http://dx.doi.org/10.1016/j.ajo.2021.05.015">[More Shah, J., Vaze, A., Tang Lee Say, T., Gillies, M., Fraser-Bell, S. Information] (2020). Emerging corticosteroid delivery platforms for Too, L., Shen, W., Mammo, Z., Osaadon, P., Gillies, M., treatment of diabetic . Expert Opinion on Simunovic, M. (2021). Surgical Retinal Explants as a Source of Emerging Drugs, 25(4), 383-394. [Mor href="http://dx.doi.org/10.1097/IAE.0000000000003137">[Mor e Information] e Information] Freude, K., McCauley, A., Paterson, C., Odette, M., Oostenink, Figueras-Roca, M., Parrado-Carrillo, A., Nguyen, V., Casaroli- A., Hyttel, P., Haukedal, H., Saruhanian, S., Kolko, M., Gillies, Marano, R., Moll-Udina, A., Gillies, M., Barthelmes, D., M. (2020). Enrichment of retinal ganglion and Muller glia Zarranz-Ventura, J. (2021). Treat-and-extend versus fixed progenitors from retinal organoids derived from human induced bimonthly treatment regimens for treatment-naive neovascular pluripotent stem cells - possibilities and current limitations. age-related macular degeneration: real world data from the World Journal of Stem Cells, 12(10), 1171-1183. [More and Experimental Ophthalmology, 259(6), 1463-1470. href="http://dx.doi.org/10.1007/s00417-020-05016-9">[More Wiryasaputra, S., Nguyen, V., Arnold, J., Ferrier, R., Information] Hinchcliffe, P., Barthelmes, D., Gillies, M. (2020). Four-week M., Ceklic, L., Gillies, M., Barthelmes, D. (2020). Prevalence outcomes of vascular endothelial growth factor inhibitors for and characteristics of macular in eyes with neovascular neovascular age-related macular degeneration. Clinical and age-related macular degeneration. A study from a long-term Experimental Ophthalmology, 48(7), 946-955. [More British Journal of Ophthalmology, 104(8), 1064-1069. href="http://dx.doi.org/10.1136/bjophthalmol-2019- 315055">[More Information] Gabrielle, P., Nguyen, V., Wolff, B., Essex, R., Young, S., Hunt, A., Gemmy Cheung, C., Milne, E., Barthelmes, D., Teo, K., Joe, A., Nguyen, V., Invernizzi, A., Milne, E., Creuzot-Garcher, C., Gillies, M. (2020). Intraocular Pressure Barthelmes, D., Gillies, M. (2020). PREVALENCE AND RISK Changes and Vascular Endothelial Growth Factor Inhibitor Use FACTORS FOR THE DEVELOPMENT OF - in Various Retinal Diseases: Long-Term Outcomes in Routine GRADED SUBRETINAL FIBROSIS IN EYES TREATED Clinical Practice: Data from the Fight Retinal Blindness! FOR NEOVASCULAR AGE-RELATED MACULAR Registry. Ophthalmology Retina, 4(9), 861-870. [More href="http://dx.doi.org/10.1097/IAE.0000000000002779">[Mor Information] e Information] Finger, R., Puth, M., Schmid, M., Barthelmes, D., Guymer, R., Bhandari, S., Nguyen, V., Fraser-Bell, S., Mehta, H., Viola, F., Gillies, M. (2020). Lifetime Outcomes of Anti-Vascular Baudin, F., Gabrielle, P., Creuzot-Garcher, C., Gillies, M., Endothelial Growth Factor Treatment for Neovascular Age- Barthelmes, D. (2020). or Aflibercept for Diabetic Related Macular Degeneration. Archives of Ophthalmology, Macular Edema: Comparison of 1-Year Outcomes from the 138(12), 1234-1240. [ 615. href="http://dx.doi.org/10.1016/j.ophtha.2019.11.018">[More Information] Fung, A., Tran, T., Lim, L., Samarawickrama, C., Arnold, J., Gillies, M., Catt, C., Mitchell, L., Symons, A., Robert, B., Gillies, M. (2020). Register your interest. Clinical and Tumuluri, K., et al (2020). Local delivery of corticosteroids in Experimental Ophthalmology, 48(4), 421-423. [More Ophthalmology, 48(3), 366-401. href="http://dx.doi.org/10.1111/ceo.13702">[More Gillies, M., Nguyen, C., Nguyen, V., Daien, V., Cohn, A., Information] Banerjee, G., Arnold, J. (2020). Reply. Ophthalmology, 127(4), Gillies, M., Hunyor, A., Arnold, J., Guymer, R., Wolf, S., e21-e22. [More in Neovascular Age-Related Macular Degeneration: A Information] Randomized Clinical Trial Comparing Ranibizumab and Zhang, R., Shen, W., Du, J., Gillies, M. (2020). Selective Aflibercept (RIVAL Study). Ophthalmology, 127(2), 198-210. knockdown of hexokinase 2 in rods leads to age-related [More Cell Death and Disease, 11(10), 1-15. href="http://dx.doi.org/10.1038/s41419-020-03103-7">[More Li, B., Zhang, T., Liu, W., Wang, Y., Xu, R., Zeng, S., Zhang, Information] R., Zhu, S., Gillies, M., Zhu, L., et al (2020). Metabolic Vittorio, A., Nguyen, V., Barthelmes, D., Arnold, J., Cheung, Features of Mouse and Human : Rods versus Cones, C., Murray, N., Gillies, M. (2020). SMOKING STATUS AND Macula versus Periphery, Retina versus RPE. iScience, 23(11), TREATMENT OUTCOMES OF VASCULAR 101672. [More NEOVASCULAR AGE-RELATED MACULAR Information] DEGENERATION. Retina, 40(9), 1696-1703. [Mor Barthelmes, D., Gillies, M. (2020). Outcomes of cataract e Information] in eyes with diabetic macular oedema: Data from the Fan, J., Shen, W., Lee, S., Mathai, A., Zhang, R., Xu, G., Fight Retinal Blindness! Registry. Clinical and Experimental Gillies, M. (2020). Targeting the Notch and TGF-β Ophthalmology, 48(4), 462-469. [More prevent retinal fibrosis in vitro and in vivo. Theranostics, Information] 10(18), 7956-7973. [More Pearlman, J., Gillies, M., Finger, R., Baldwin, M., Leitch, I. Information] (2020). Phase 1 Study of OPT-302 Inhibition of Vascular Wolff, B., Macioce, V., Vasseur, V., Castelnovo, L., Michel, Endothelial Growth Factors C and D for Neovascular Age- G., Nguyen, V., Daien, V., Mauget-Fa�sse, M., Gillies, M. Related Macular Degeneration. Ophthalmology Retina, 4(3), (2020). Ten-year outcomes of anti-vascular endothelial growth 250-263. [More single-centre French study. Clinical and Experimental Information] Ophthalmology, 48(5), 636-643. [More Lee, S., Yam, M., Cornish, E., Fraser-Bell, S., Gillies, M., et al Information] (2020). Preclinical and clinical studies of photobiomodulation Gillies, M., Arnold, J., Bhandari, S., Essex, R., Young, S., therapy for macular oedema. Diabetologia, 63(9), 1900-1915. Squirrell, D., Nguyen, V., Barthelmes, D. (2020). Ten-Year [More Information] Degeneration from two regions. American Journal of Daien, V., Nguyen, V., Essex, R., Essex, R., Milne, E., Munk, Ophthalmology, 210, 116-124. [More Chung, S., Shen, W., Davidson, K., P�bay, A., Wong, R., Information] Yau, B., Gillies, M. (2019). Differentiation of Retinal Glial Cells From Human Embryonic Stem Cells by Promoting the Fraser-Bell, S., Gillies, M. (2020). The impact of the Lucentis, Notch Signaling Pathway. Frontiers in Cellular Neuroscience, Eylea, Avastin in Vein Occlusion (LEAVO) Study in Australia. 13, 1-9. [More 019-0713-7">[More Information] Information] Bhandari, S., Nguyen, V., Arnold, J., Young, S., Banerjee, G., Chew, E., Clemons, T., Jaffe, G., Johnson, C., Farsiu, S., Lad, Gillies, M., Barthelmes, D. (2020). Treatment Outcomes of E., Guymer, R., Rosenfeld, P., Hubschman, J., Gillies, M., et al Ranibizumab versus Aflibercept for Neovascular Age-Related (2019). Effect of Ciliary Neurotrophic Factor on Retinal Macular Degeneration: Data from the Fight Retinal Blindness! in Patients with Macular Telangiectasia Registry. Ophthalmology, 127(3), 369-376. [More 540-549. href="http://dx.doi.org/10.1016/j.ophtha.2018.09.041">[More Invernizzi, A., Pichi, F., Symes, R., Zagora, S., Agarwal, A., Information] Nguyen, P., Erba, S., Xhepa, A., De Simone, L., Cimino, L., Gillies, M., Hunyor, A., Arnold, J., Guymer, R., Wolf, S., Ng, Gillies, M., McCluskey, P. (2020). Twenty-four-month P., Pecheur, F., McAllister, I. (2019). Effect of Ranibizumab outcomes of inflammatory choroidal neovascularisation treated and Aflibercept on Best-Corrected Visual Acuity in Treat-and- with intravitreal anti-vascular endothelial growth factors: A Extend for Neovascular Age-Related Macular Degeneration: A comparison between two treatment regimens. British Journal of Randomized Clinical Trial. JAMA Ophthalmology, 137(4), 372- Ophthalmology, 104(8), 1052-1056. [ 315257">[More Information] More Information] 2019 Bahrami, B., Shen, W., Zhu, L., Zhang, T., Chang, A., Gillies, M. (2019). Effects of VEGF inhibitors on human retinal Teo, K., Squirrell, D., Nguyen, V., Banerjee, G., Cohn, A., pigment epithelium under high glucose and hypoxia. Clinical Barthelmes, D., Cheung, C., Gillies, M. (2019). A Multicountry and Experimental Ophthalmology, 47(8), 1074-1081. [More Polypoidal Choroidal Vasculopathy: Fight Retinal Blindness! Information] Cohort. Ophthalmology Retina, 3(3), 220-229. [More You, Y., Zhu, L., Zhang, T., Shen, T., Fontes, A., Yiannikas, Information] C., Parratt, J., Barton, J., Schulz, A., Gupta, V., Barnett, M., Fraser, C., Gillies, M., Graham, S., Klistorner, A. (2019). Lukowski, S., Lo, C., Sharov, A., Nguyen, Q., Fang, L., Hung, Evidence of Muller Glial Dysfunction in Patients with S., Zhu, L., Zhang, T., Grunert, U., Nguyen, T., Gillies, M., et Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica al (2019). A single-cell transcriptome atlas of the adult human Spectrum Disorder. Ophthalmology, 126(6), 801-810. [More href="http://dx.doi.org/10.15252/embj.2018100811">[More Information] Information] Invernizzi, A., Nguyen, V., Teo, K., Barthelmes, D., Fung, A., Williams, L., Javed, A., Sabri, A., Morgan, D., Huff, C., Grigg, Vincent, A., Gillies, M. (2019). Five-Year Real-World J., Heng, X., Khng, A., Hollink, I., Morrison, M., Greenlees, R., Outcomes of Occult and Classic Choroidal : Cheng, A., Zheng, L., Gillies, M., Chircop (nee Fabbro), M., Data From the Fight Retinal Blindness! Project. American Jamieson, R., et al (2019). ALPK1 missense pathogenic variant Journal of Ophthalmology, 204, 105-112. [More multisystem autosomal dominant disorder. Genetics in Information] , 21(9), 2103-2115. [More Zhang, T., Zhu, L., Madigan, M., Liu, W., Shen, W., Information] Cherepanoff, S., Zhou, F., Zeng, S., Du, J., Gillies, M. (2019). Human macular Muller cells rely more on serine biosynthesis to Nguyen, C., Gillies, M., Nguyen, V., Daien, V., Cohn, A., combat oxidative stress than those from the periphery. eLife, 8, Banerjee, G., Arnold, J. (2019). Characterization of poor visual 1-19. [More outcomes of neovascular age-related macular degeneration Information] treated with anti-vascular endothelial growth factor agents. Ophthalmology, 126(5), 735-742. [More Essex, R., Chang, J., Pal, B., Daniell, M., Lake, S., Jenkins, A., Information] et al (2019). MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Tan, J., Ferdi, A., Gillies, M., Watson, S. (2019). Clinical Mellitus. Investigative Ophthalmology and Visual Science, Registries in Ophthalmology. Ophthalmology, 126(5), 655-662. 60(12), 3937-3942. [More Information] href="http://dx.doi.org/10.1016/j.ophtha.2018.12.030">[More Information] Liu, E., Kaidonis, G., Gillies, M., Abhary, S., Essex, R., Chang, J., Pal, B., Daniell, M., Lake, S., Gilhotra, J., Jenkins, A., et al Mehta, H., Lim, L., Nguyen, V., Qatarneh, D., (2019). Mitochondrial haplogroups are not associated with Wickremasinghe, S., Hodgson, L., Quin, G., McAllister, I., diabetic retinopathy in a large Australian and British Caucasian Gillies, M., Fraser-Bell, S. (2019). Development of New sample. Scientific Reports, 9(1), 1-7. [More Ophthalmology Retina, 3(3), 286-287. href="http://dx.doi.org/10.1016/j.oret.2018.10.010">[More Information] Gillies, M., Cornish, E. (2019). Myopic choroidal neovascularization: To load or not to load. Clinical and Experimental Ophthalmology, 47(2), 161-162. [More Invernizzi, A., Teo, K., Nguyen, V., Daniell, M., Squirrell, D., Information] Barthelmes, D., Gillies, M. (2019). Type 3 neovascularisation (retinal angiomatous proliferation) treated with antivascular Lee, M., Marshall, N., Clemons, T., Hunter, M., James, A., endothelial growth factor: real-world outcomes at 24 months. Grunstein, R., Nguyen, V., Campain, A., Gillies, M. (2019). No British Journal of Ophthalmology, 103(9), 1337-1341. [More Information] control study and retrospective cohort study. Clinical and Experimental Ophthalmology, 47(1), 63-68. [More Information] Shen, W., Lee, S., Yam, M., Zhu, L., Zhang, T., Pye, V., Mathai, A., Shibagaki, K., Zhang, J., Matsugi, T., Gillies, M. Simunovic, M., Shen, W., Lin, J., Protti, D., Lisowski, L., (2018). A Combination Therapy Targeting Endoglin and VEGF- Gillies, M. (2019). Optogenetic approaches to vision A Prevents Subretinal Fibro-Neovascularization Caused by restoration. Experimental Eye Research, 178, 15-26. [More and Visual Science, 59(15), 6075-6088. href="http://dx.doi.org/10.1167/iovs.18-25628">[More Nguyen, V., Vaze, A., Fraser-Bell, S., Arnold, J., Essex, R., Information] Barthelmes, D., Gillies, M. (2019). Outcomes of Suspending Barthelmes, D., Nguyen, V., Walton, R., Gillies, M., Daien, V. VEGF Inhibitors for Neovascular Age-Related Macular (2018). A pharmacoepidemiologic study of ranibizumab and Degeneration When Lesions Have Been Inactive for 3 Months. aflibercept use 2013�2016. The Fight Retinal Blindness! Ophthalmology Retina, 3(8), 623-628. [More Ophthalmology, 256(10), 1839-1846. href="http://dx.doi.org/10.1007/s00417-018-4061-2">[More Nguyen, V., Daien, V., Guymer, R., Young, S., Hunyor, A., Information] Fraser-Bell, S., Hunt, A., Gillies, M., Barthelmes, D. (2019). Mehta, H., Hennings, C., Gillies, M., Nguyen, V., Campain, A., Projection of Long-Term Visual Acuity Outcomes Based on Fraser-Bell, S. (2018). Anti-vascular endothelial growth factor Initial Treatment Response in Neovascular Age-Related combined with intravitreal steroids for diabetic macular Macular Degeneration. Ophthalmology, 126(1), 64-74. [More 70. href="http://dx.doi.org/10.1002/14651858.CD011599.pub2">[M Gantner, M., Eade, K., Wallace, M., Handzlik, M., Fallon, R., ore Information] Trombley, J., Bonelli, R., Giles, S., Harkins-Perry, S., Heeren, Zhu, L., Shen, W., Zhang, T., Wang, Y., Bahrami, B., Zhou, F., T., Gillies, M., et al (2019). Serine and Lipid in Gillies, M. (2018). Characterization of canonical Wnt signalling Macular Disease and Peripheral Neuropathy. New England changes after induced disruption of Muller cell in murine retina. Journal of Medicine, 381(15), 1422-1433. [More href="http://dx.doi.org/10.1016/j.exer.2018.06.016">[More Information] Information] Zhang, T., Gillies, M., Wang, Y., Shen, W., Bahrami, B., Zeng, Invernizzi, A., Benatti, E., Cozzi, M., Erba, S., Vaishnavi, S., S., Zhu, M., Yao, W., Zhou, F., Murray, M., Zhu, L., et al Vupparaboina, K., Staurenghi, G., Chhablani, J., Gillies, M., (2019). Simvastatin Protects Photoreceptors from all-trans- Viola, F. (2018). Choroidal Structural Changes Correlate With retinal Induced Oxidative Stress with Up-regulation of Neovascular Activity in Neovascular Age Related Macular Interphotoreceptor Retinoid Binding Protein. British Journal of Degeneration. Investigative Ophthalmology and Visual Science, Pharmacology, 176(12), 2063-2078. [More 23960">[More Information] Information] Nguyen, V., Daien, V., Guymer, R., McAllister, I., Morlet, N., Ting, K., Zhao, Y., Shen, W., Coleman, P., Yam, M., Chan- Barthelmes, D., Gillies, M. (2018). Clinical and social Ling, T., Li, J., Moller, T., Gillies, M., Vadas, M., Gamble, J. characteristics associated with reduced visual acuity at (2019). Therapeutic regulation of VE-cadherin with a novel presentation in Australian patients with neovascular age-related oligonucleotide drug for diabetic eye complications using macular degeneration: a prospective study from a long-term retinopathy mouse models. Diabetologia, 62(2), 322-334. [More Clinical and Experimental Ophthalmology, 46(3), 266-274. href="http://dx.doi.org/10.1111/ceo.13038">[More Guymer, R., Markey, C., McAllister, I., Gillies, M., Hunyor, A., Information] Arnold, J. (2019). Tolerating Subretinal Fluid in Neovascular Zhang, T., Gillies, M., Madigan, M., Shen, W., Du, J., Grunert, Age-Related Macular Degeneration Treated With Ranibizumab U., Zhou, F., Yam, M., Zhu, L. (2018). Disruption of De Novo Using a Treat-and-Extend Regimen: FLUID Study 24 Month Serine Synthesis in Müller Cells Induced Mitochondrial Results. Ophthalmology, 126(5), 723-734. [More Neurobiology, 55(8), 7025-7037. href="http://dx.doi.org/10.1007/s12035-017-0840-8">[More Essex, R., Nguyen, V., Daien, V., Steinmann, S., Walton, R., Information] Gillies, M., Barthelmes, D. (2019). Trainee-led versus specialist- Invernizzi, A., Nguyen, V., Arnold, J., Young, S., Barthelmes, led management of neovascular age-related macular D., Gillies, M. (2018). Early and Late Retinal Pigment degeneration: a registry-based study. British Journal of Epithelium Tears after Anti-Vascular Endothelial Growth Ophthalmology, 103(8), 1158-1162. [More Information] href="http://dx.doi.org/10.1016/j.ophtha.2017.08.039">[More M., Barthelmes, D., Gillies, M. (2018). Real-world outcomes in Information] patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor Powner, M., Woods, S., Zhu, M., Gillies, M., Bernstein, P., inhibitors. Progress in Retinal and Eye Research, 65, 127-146. Hageman, G., Comer, G., Egan, C., Fruttiger, M. (2018). [Mor In Macular Telangiectasia Type 2. Retina, 38(Supple1), S105- e Information] S113. [Mor Ozturk, M., Harris, M., Nguyen, V., Barthelmes, D., Gillies, e Information] M., Mehta, H. (2018). Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving Graham, P., Kaidonis, G., Abhary, S., Gillies, M., Daniell, M., aflibercept at fixed intervals as per UK licence. Clinical and Essex, R., Chang, J., Lake, S., Pal, B., Jenkins, A., et al (2018). Experimental Ophthalmology, 46(4), 407-411. [More and proliferative diabetic retinopathy. BMC , Information] 19(1), 1-8. [More Information] Invernizzi, A., Nguyen, V., Gillies, M. (2018). Relationship between reticular pseudodrusen and choroidal thickness in Irhimeh, M., Hamed, M., Barthelmes, D., Gladbach, Y., Helms, intermediate age-related macular degeneration: comment. V., Shen, W., Gillies, M. (2018). Identification of novel Clinical and Experimental Ophthalmology, 46(8), 966-967. [More networks in bone marrow-derived Lin-/VEGF-R2+ endothelial Information] progenitor cells. PloS One, 13(7), 1-20. [More Ao, J., Wood, J., Chidlow, G., Gillies, M., Casson, R. (2018). Information] Retinal pigment epithelium in the pathogenesis of age-related macular degeneration and photobiomodulation as a potential Midena, E., Gillies, M., Katz, T., Metzig, C., Lu, C., Ogura, Y. therapy? Clinical and Experimental Ophthalmology, 46(6), 670- (2018). Impact of Baseline Central Retinal Thickness on 686. [More Outcomes in the VIVID-DME and VISTA-DME Studies. Information] Journal of Ophthalmology, 2018, 1-9. [More Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. Information] (2018). Short-term vision gains at 12 weeks correlate with long- term vision gains at 2 years: results from the BEVORDEX Daien, V., Nguyen, V., Essex, R., Morlet, N., Barthelmes, D., randomised clinical trial of versus dexamethasone Gillies, M. (2018). Incidence and Outcomes of Infectious and implants for diabetic macular oedema. British Journal of Noninfectious Endophthalmitis after Intravitreal Injections for Ophthalmology, 102(4), 479-482. [More Information] href="http://dx.doi.org/10.1016/j.ophtha.2017.07.005">[More Information] Mantel, I., Gillies, M., Souied, E. (2018). Switching between ranibizumab and aflibercept for the treatment of neovascular Invernizzi, A., Pellegrini, M., Acquistapace, A., Benatti, E., age-related macular degeneration. Survey of Ophthalmology, Erba, S., Cozzi, M., Cigada, M., Viola, F., Gillies, M., 63(5), 638-645. [M Thickness Maps Generated by Spectral-Domain OCT in a ore Information] White Population. Ophthalmology Retina, 2(8), 808-815.e1. [More Mehta, H., Fraser-Bell, S., Nguyen, V., Lim, L., Gillies, M. Information] (2018). The Interval between Treatments of Bevacizumab and Dexamethasone Implants for Diabetic Macular Edema Daien, V., Nguyen, V., Morlet, N., Arnold, J., Essex, R., Increased over Time in the BEVORDEX Trial. Ophthalmology Young, S., Hunyor, A., Gillies, M., Barthelmes, D. (2018). Retina, 2(3), 231-234. [More patients with neovascular age-related macular degeneration The Information] Fight Retinal Blindness! Project. American Journal of Ophthalmology, 190, 50-57. [More endothelial growth factor inhibitors and complementary Information] treatment options in polypoidal choroidal vasculopathy: A subtype of neovascular age-related macular degeneration. Lowry, E., Nguyen, V., Daien, V., Barthelmes, D., Gillies, M. International Journal of Molecular Sciences, 19(9), 1-14. [More Degeneration when Neovascular Lesion Activity Is Uncertain: Information] Observational Study. Ophthalmology Retina, 2(6), 531-538. [More Barthelmes, D., Nguyen, V., Daien, V., Campain, A., Walton, Information] R., Guymer, R., Morlet, N., Hunyor, A., Essex, R., Arnold, J., Gillies, M. (2018). Two Year Outcomes Of "Treat And Extend" Vaze, A., Nguyen, V., Daien, V., Arnold, J., Young, S., Intravitreal Therapy Using Aflibercept Preferentially For Cheung, C., Lamoureux, E., Bhargava, M., Barthelmes, D., Neovascular Age-Related Macular Degeneration. Retina, 38(1), Gillies, M. (2018). Ranibizumab And Aflibercept For The 20-28. [Mor Age-Related Macular Degeneration: Data From An e Information] Observational Study. Retina, 38(10), 1954-1961. [Mor 2017 e Information] Baumann, B., Sterling, J., Song, Y., Song, D., Fruttiger, M., Mehta, H., Tufail, A., Daien, V., Lee, A., Nguyen, V., Ozturk, Gillies, M., Shen, W., Dunaief, J. (2017). Conditional Muller cell ablation leads to retinal iron accumulation. Investigative for diabetic macular oedema: a review. Clinical and Ophthalmology and Visual Science, 58(10), 4223-4234. [More href="http://dx.doi.org/10.1111/ceo.12757">[More Information] Information] Shen, W., Yau, B., Lee, S., Zhu, L., Yam, M., Gillies, M. Rodrigues, I., Sprinkhuizen, S., Barthelmes, D., Blumenkranz, (2017). Effects of Ranibizumab and Aflibercept on Human M., Cheung, G., Haller, J., Johnston, R., Kim, R., Klaver, C., Muller Cells and Photoreceptors under Stress Conditions. McKibbin, M., Gillies, M., et al (2016). Defining a Minimum International Journal of Molecular Sciences, 18(3), 1-16. [More Macular Degeneration. American Journal of Ophthalmology, Information] 168, 1-12. [More Mehta, H., Muller, S., Egan, C., Degli Esposti, S., Tufail, A., Information] Sim, D., Holz, F., Browning, A., Amoaku, W., Issa, P., Gillies, M. (2017). Natural history and effect of therapeutic Chung, S., Gillies, M., Yam, M., Wang, Y., Shen, W. (2016). interventions on subretinal fluid causing foveal detachment in Differential expression of microRNAs in retinal vasculopathy macular telangiectasia type 2. British Journal of caused by selective M�ller cell disruption. Scientific Reports, Ophthalmology, 101(7), 955-959. [More href="http://dx.doi.org/10.1136/bjophthalmol-2016- Information] 309237">[More Information] Daien, V., Papinaud, L., Gillies, M., Domerg, C., Nagot, N., Gillies, M., Daien, V., Nguyen, V., Barthelmes, D. (2017). Re: Lacombe, S., Daures, J., Carriere, I., Villian, M. (2016). Comparison of Age-Related Macular Degeneration Treatments Effectiveness and safety of an intracameral injection of Trials (CATT) Research Group, et�al.: Five-year outcomes cefuroxime for the prevention of endophthalmitis after cataract with anti-vascular endothelial growth factor treatment of surgery with or without perioperative capsular rupture. JAMA neovascular age-related macular degeneration: The Comparison Ophthalmology, 134(7), 810-816. [ (Ophthalmology 2016;123:1751-1761). Ophthalmology, 124(3), More Information] e31-e32. [More McAllister, I., Simpson, J., Hunyor, A., Guymer, R., Essex, R., Information] Morlet, N., Gillies, M. (2016). Effects of switching from Wickremasinghe, S., Fraser-Bell, S., Alessandrello, E., Mehta, ranibizumab to aflibercept in eyes with exudative age-related H., Gillies, M., Lim, L. (2017). Retinal vascular calibre changes macular degeneration. British Journal of Ophthalmology, after intravitreal bevacizumab or dexamethasone implant 100(12), 1640-1645. [More Information] href="http://dx.doi.org/10.1136/bjophthalmol-2016- Mehta, H., Fraser-Bell, S., Yeung, A., Campain, A., Lim, L., 309882">[More Information] Quin, G., McAllister, I., Keane, P., Gillies, M. (2016). Efficacy Razavi, H., Walton, R., Gillies, M., Guymer, R. (2017). Seven- of dexamethasone versus bevacizumab on regression of hard year Trends in Visual Acuity at First Presentation in Patients exudates in diabetic maculopathy: Data from the BEVORDEX with Neovascular AMD. Ophthalmology, 124(2), 270-272. [More 100(7), 1000-1004. href="http://dx.doi.org/10.1136/bjophthalmol-2015- 307797">[More Information] 2016 Tao, Z., Zhao, C., Jian, Q., Gillies, M., Xu, H., Yin, Z. (2016). Kaidonis, G., Gillies, M., Abhary, S., Liu, E., Essex, R., Chang, Lin28B promotes m�ller glial cell de-differentiation and J., Pal, B., Sivaprasad, S., Pefkianaki, M., Daniell, M., et al proliferation in the regenerative rat retinas. Oncotarget, 7(31), (2016). A single-nucleotide polymorphism in the MicroRNA- 49368-49383. [More threatening diabetic retinopathy in Caucasian patients. Acta Information] Diabetologica, 53(4), 643-650. [More (2016). Metaanalysis of real-world outcomes of intravitreal Information] ranibizumab for the treatment of neovascular age-related Fraser-Bell, S., Lim, L., Campain, A., Mehta, H., Aroney, C., macular degeneration. Retina, 36(8), 1418-1431. [Mor Bevacizumab or Dexamethasone Implants for DME: 2-year e Information] Results (The BEVORDEX Study). Ophthalmology, 123(6), Kaidonis, G., Craig, J., Gillies, M., Abhary, S., Essex, R., 1399-1401. [More (2016). Promoter polymorphism at the tumour necrosis Information] factor/lymphotoxin-alpha locus is associated with type of Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W., Madigan, M., diabetes but not with susceptibility to sight-threatening diabetic Gillies, M., Zhou, F. (2016). Chloroquine and retinopathy. Diabetes and Vascular Disease Research, 13(2), Hydroxychloroquine Are Novel Inhibitors of Human Organic 164-167. [More Pharmaceutical Sciences, 105(2), 884-890. href="http://dx.doi.org/10.1002/jps.24663">[More Zheng, L., Gillies, M., Martin, F. (2016). Reply. Journal of Information] American Association for Pediatric Ophthalmology and Mehta, H., Gillies, M., Fraser-Bell, S. (2016). Combination of Strabismus, 20(2), 187-188. [More Information] Information] Vaze, A., Gillies, M. (2016). Salient features and management Chung, S., Shen, W., Gillies, M. (2015). Genomic Analysis options of macular telangiectasia type 2: a review and update. Using Affymetrix Standard Microarray GeneChips (169 Expert Review of Ophthalmology, 11(6), 429-441. [Mor Adalberto Merighi (Eds.), Neuronal Cell Death: Methods and e Information] Protocols, (pp. 129-140). New York: Springer Science+Business Media. [More Guymer, R., Morlet, N., Young, S., Barthelmes, D., Gillies, M. Information] (2016). Treatment Patterns and Visual Outcomes during the Maintenance Phase of Treat-and-Extend Therapy for Age- Chan, T., Zhu, L., Madigan, M., Wang, K., Shen, W., Gillies, Related Macular Degeneration. Ophthalmology, 123(11), 2393- M., Zhou, F. (2015). Human organic anion transporting 2400. [More trans-retinol in human retinal pigmented epithelial cells. British Information] Journal of Pharmacology, 172(9), 2343-2353. [More Gillies, M., Nguyen, V., Daien, V., Arnold, J., Morlet, N., Information] Barthelmes, D. (2016). Twelve-Month Outcomes of Ranibizumab vs. Aflibercept for Neovascular Age-Related Gillies, M., Campain, A., Barthelmes, D., Simpson, J., Arnold, Macular Degeneration: Data from an Observational Study. J., Guymer, R., McAllister, I., Essex, R., Morlet, N., Hunyor, A. Ophthalmology, 123(12), 2545-2553. [More Age-Related Macular Degeneration: Data from an Information] Observational Study. Ophthalmology, 122(9), 1837-1845. [More Aroney, C., Fraser-Bell, S., Lamoureux, E., Gillies, M., Lim, Information] L., Fenwick, E. (2016). Vision-related quality of life outcomes in the BEVORDEX study: A clinical trial comparing ozurdex Gillies, M., Mehta, H., Bird, A. (2015). Macular telangiectasia sustained release dexamethasone intravitreal implant and type 2 without clinically detectable vasculopathy. JAMA bevacizumab treatment for diabetic macular edema. Ophthalmology, 133(8), 951-954. [ 5546. [More Information] Barthelmes, D., Walton, R., Campain, A., Simpson, J., Arnold, 2015 J., McAllister, I., Guymer, R., Hunyor, A., Essex, R., Morlet, N., Gillies, M. (2015). Outcomes of persistently active Zheng, L., Gillies, M., Martin, F. (2015). Central retinal vein neovascular age-related macular degeneration treated with occlusion in an otherwise healthy child treated successfully VEGF inhibitors: Observational study data. The British Journal with a single injection of bevacizumab. Journal of American of Ophthalmology, 99(3), 359-364. [More Information] href="http://dx.doi.org/10.1016/j.jaapos.2015.04.012">[More Au, C., Fardell, N., Williams, M., Fraser-Bell, S., Campain, A., Information] Gillies, M. (2015). Patient experiences in retinal trials: a cross- Kaidonis, G., Burdon, K., Gillies, M., Abhary, S., Essex, R., sectional study. BMC Ophthalmology, 15(1), 1-7. [More Jenkins, A., et al (2015). Common Sequence Variation in the Information] VEGFC Gene Is Associated with Diabetic Retinopathy and Mehta, H., Gillies, M., Fraser-Bell, S. (2015). Perspective on Diabetic Macular Edema. Ophthalmology, 122(9), 1828-1836. the role of Ozurdex (dexamethasone intravitreal implant) in the [More Advances in Chronic Diseases, 6(5), 234-245. href="http://dx.doi.org/10.1177/2040622315590319">[More Coorey, N., Shen, W., Zhu, L., Gillies, M. (2015). Differential Information] Expression of IL-6/gp130 Cytokines, Jak-STAT Signalling and Chung, S., Gillies, M., Sugiyama, Y., Zhu, L., Lee, S., Shen, W. Neuroprotection After Muller Cell Ablation in a Transgenic (2015). Profiling of MicroRNAs Involved in Retinal Mouse Model. Investigative Ophthalmology and Visual Degeneration Caused by Selective Müller Cell Ablation. PloS Science, 56(4), 2151-2161. [More href="http://dx.doi.org/10.1371/journal.pone.0118949">[More Information] Information] Zhu, L., Shen, W., Lyons, B., Wang, Y., Zhou, F., Gillies, M. Quin, G., Lyons, B., Len, A., Madigan, M., Gillies, M. (2015). (2015). Dysregulation of inter-photoreceptor retinoid-binding Proteome changes induced by laser in diabetic retinopathy. protein (IRBP) after induced Muller cell disruption. Journal of Clinical and Experimental Ophthalmology, 43(2), 180-187. [More href="http://dx.doi.org/10.1111/jnc.13075">[More Information] Information] Xu, C., Zhu, L., Chan, T., Lu, X., Shen, W., Gillies, M., Zhou, Burdon, K., Fogarty, R., Shen, W., Abhary, S., Kaidonis, G., F. (2015). The altered renal and hepatic expression of solute Appukuttan, B., Hewitt, A., Sharma, S., Daniell, M., Essex, R., carrier transporters (SLCs) in type 1 diabetic mice. PloS One, Jenkins, A., Gillies, M., et al (2015). Genome-wide association 10(3), 1-14. [More association with genetic variation near the GRB2 gene. Information] Diabetologia, 58(10), 2288-2297. [More Gillies, M., Campain, A., Walton, R., Simpson, J., Arnold, J., Guymer, R., McAllister, I., Hunyor, A., Essex, R., Morlet, N., and Experimental Ophthalmology, 42(5), 486-493. [More inactivation of neovascular age-related macular degeneration Information] treated primarily with ranibizumab. Ophthalmology, 122(3), Zhang, X., Wang, N., Schachat, A., Bao, B., Gillies, M. (2014). 589-594. [More Mechanisms in the Treatment of Diabetic Retinopathy and Information] Diabetic Macular Edema. Current Molecular Medicine, 14(3), Arnold, J., Campain, A., Barthelmes, D., Simpson, J., Guymer, 376-384. [More Information] therapy for neovascular age-related macular degeneration". Chung, S., Shen, W., Gillies, M. (2014). Identification of a Ophthalmology, 122(6), 1212-1219. [More Non-coding RNAs Endocrinol, 1(1), 28-30. href="http://dx.doi.org/10.2478/micrnado-2014-0001">[More 2014 Information] O'Day, R., Barthelmes, D., Zhu, M., Wong, T., McAllister, I., Gillies, M., Lim, L., Campain, A., Quin, G., Salem, W., Li, J., Arnold, J., Gillies, M. (2014). Intraocular pressure rise is Goodwin, S., Aroney, C., McAllister, I., Fraser-Bell, S. (2014). predictive of vision improvement after intravitreal A Randomized Clinical Trial of Intravitreal Bevacizumab triamcinolone acetonide for diabetic macular oedema: a versus Intravitreal Dexamethasone for Diabetic Macular retrospective analysis of data from a randomised controlled Edema: The BEVORDEX Study. Ophthalmology, 121(12), trial. BMC Ophthalmology, 14(1), 1-5. [More href="http://dx.doi.org/10.1016/j.ophtha.2014.07.002">[More Information] Information] Barthelmes, D., Walton, R., Arnold, J., McAllister, I., Simpson, Gillies, M., Walton, R., Arnold, J., McAllister, I., Simpson, J., J., Campain, A., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Hunyor, A., Guymer, R., Essex, R., Morlet, N., Barthelmes, D. Gillies, M. (2014). Intravitreal Therapy in Bilateral Neovascular (2014). Comparison of outcomes from a phase 3 study of age- Age-Related Macular Degeneration. Ophthalmology, 121(10), related macular degeneration with a matched, observational 2073-2074. [More href="http://dx.doi.org/10.1016/j.ophtha.2013.09.050">[More Information] Information] Shibeeb, O., Vaze, A., Gillies, M., Gray, T. (2014). Macular Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Consequences of oedema in idiopathic macular telangiectasia type 1 responsive long-term discontinuation of vascular endothelial growth factor to aflibercept but not bevacizumab. Case Reports in inhibitor therapy in the patients with neovascular age-related Ophthalmological Medicine, 2014, 1-4. [More e698. [More Information] Information] Tan, M., McAllister, I., Gillies, M., Verma, N., Banerjee, G., Zhang, X., Zeng, H., Bao, B., Wang, N., Gillies, M. (2014). Smithies, L., Wong, W., Wong, T. (2014). Randomized Diabetic macular edema: New concepts in patho-physiology controlled trial of intravitreal ranibizumab versus standard grid and treatment. Cell and Bioscience, 4, 1-14. [More occlusion. American Journal of Ophthalmology, 157(1), 237- Information] 247. [More (2014). Differential gene expression in Lin-/VEGF-R2+ bone Information] marrow-derived endothelial progenitor cells isolated from Vaze, A., Fraser-Bell, S., Gillies, M. (2014). Reasons for diabetic mice. Cardiovascular Diabetology, 13(1), 1-10. [More factor inhibitors in neovascular age-related macular Information] degeneration. Retina, 34(9), 1774-1778. [Mor (2014). Effect of glucocorticoids on neuronal and vascular e Information] in a transgenic model of selective Muller cell O'Day, R., Walton, R., Blennerhassett, R., Gillies, M., ablation. GLIA, 62(7), 1110-1124. [More controlled trials in ophthalmology. British Journal of Information] Ophthalmology, 98(8), 1003-1008. [More Information] Herrera-Bond, P., Glastonbury, B., Simpson, J., Barthelmes, D. Shen, W., Chung, S., Irhimeh, M., Li, S., Lee, S., Gillies, M. (2014). Efficient capture of high-quality data on outcomes of (2014). Systemic Administration of Erythropoietin Inhibits treatment for macular diseases: The Fight Retinal Blindness! Retinopathy in RCS Rats. PloS One, 9(8), 1-14. [More href="http://dx.doi.org/10.1097/IAE.0b013e318296b271">[Mor Information] e Information] Finger, R., Guymer, R., Gillies, M., Keeffe, J. (2014). The Kaidonis, G., Abhary, S., Daniell, M., Gillies, M., Fogarty, R., Impact of Anti-Vascular Endothelial Growth Factor Treatment Petrovsky, N., Jenkins, A., Essex, R., Chang, J., Pal, B., et al on Quality of Life in Neovascular Age-related Macular (2014). Genetic study of diabetic retinopathy: Recruitment Degeneration. Ophthalmology, 121(6), 1246-1251. [More Science, 54(10), 6578-6584. href="http://dx.doi.org/10.1167/iovs.13-12311">[More Information] 2013 Powner, M., Gillies, M., Zhu, M., Vevis, K., Hunyor, A., Zhu, L., Shen, W., Zhu, M., Coorey, N., Nguyen, A., Fruttiger, M. (2013). Loss of Müller's cells and Barthelmes, D., Gillies, M. (2013). Anti-Retinal Antibodies in photoreceptors in macular telangiectasia type 2. Patients With Macular Telangiectasia Type 2. Investigative Ophthalmology, 120(11), 2344-2352. [More href="http://dx.doi.org/10.1167/iovs.13-12050">[More Information] Information] Issa, P., Gillies, M., Chew, E., Bird, A., Heeren, T., Peto, T., O'Day, R., Barthelmes, D., Zhu, M., Wong, T., McAllister, I., Holz, F., Scholl, H. (2013). Macular telangiectasia type 2. Arnold, J., Gillies, M. (2013). Baseline central macular Progress in Retinal and Eye Research, 34, 49-77. [Mor triamcinolone plus laser photocoagulation for diabetic macular e Information] edema. Clinical Ophthalmology, 7, 1565-1570. [More Mitchell, P., Ramdas, W., Vingerling, J. (2013). Medical Information] Characteristics of Patients with Macular Telangiectasia Type 2 Liew, G., Quin, G., Gillies, M., Fraser-Bell, S. (2013). Central (MacTel Type 2) MacTel Project Report No. 3. Ophthalmic serous chorioretinopathy: a review of Epidemiology, 20(2), 109-113. [More Ophthalmology, 41(2), 201-214. href="http://dx.doi.org/10.1111/j.1442- Kemp, A., Preen, D., Morlet, N., CLARK, A., McAllister, I., 9071.2012.02848.x">[More Information] BRIFFA, T., SANFILIPPO, F., Ng, J., MCKNIGHT, C., Barthelmes, D., Irhimeh, M., Gillies, M., Karimipour, M., REYNOLDS, W., Gillies, M. (2013). Myocardial infarction Zhou, M., Zhu, L., Shen, W. (2013). Diabetes impairs after intravitreal vascular endothelial growth factor inhibitors: A mobilization of mouse bone marrow-derived Lin-/VEGF-R2+ whole population study. Retina, 33(5), 920-927. [Mor 163-173. href="http://dx.doi.org/10.1016/j.bcmd.2013.05.002">[More O'Day, R., Gillies, M., Ahlenstiel, G. (2013). Ophthalmologic Information] complications of antiviral therapy in hepatitis C treatment. Zhang, X., Wang, N., Barile, G., Bao, B., Gillies, M. (2013). World Journal of , 19(45), 8227-8237. [More International Journal of Biochemistry and Cell Biology, 45(7), Information] 1525-1529. [More McAllister, I., Hunyor, A., Essex, R., Mortlet, N., Barthelmes, Information] D. (2013). Prospective Audit of Exudative Age-Related Quin, G., Liew, G., Ho, I., Gillies, M., Fraser-Bell, S. (2013). Macular Degeneration: 12-month Outcomes in Treatment- Diagnosis and interventions for central serous Naive eyes. Investigative Ophthalmology and Visual Science, chorioretinopathy: review and update. Clinical and 54(8), 5754-5760. [More Information] href="http://dx.doi.org/10.1111/j.1442- Holz, F., Bandello, F., Gillies, M., Mitchell, P., Osborne, A., 9071.2012.02847.x">[More Information] Sheidow, T., Souied, E., Figueroa, M. (2013). Safety of Chung, S., Shen, W., Jayawardana, K., Wang, P., Yang, J., ranibizumab in routine clinical practice: 1-year retrospective Shackel, N., Gillies, M. (2013). Differential gene expression pooled analysis of four European neovascular AMD registries profiling after conditional müller-cell ablation in a novel within the LUMINOUS programme. British Journal of transgenic model. Investigative Ophthalmology and Visual Ophthalmology, 97(9), 1161-1167. [More 303232">[More Information] Information] Zhu, M., Krilis, M., Gillies, M. (2013). The relationship Shen, W., Zhu, L., Lee, S., Chung, S., Gillies, M. (2013). between inner retinal cavitation, photoreceptor disruption, and Involvement of NT3 and P75NTR in photoreceptor the integrity of the outer limiting membrane in macular degeneration following selective Muller cell ablation. Journal telangiectasia type 2. Retina, 33(8), 1547-1550. [Mor href="http://dx.doi.org/10.1186/1742-2094-10-137">[More e Information] Information] Zhang, X., Lai, D., Bao, B., Hambly, B., Gillies, M. (2013). Barthelmes, D., Irhimeh, M., Gillies, M., Zhu, L., Shen, W. Triamcinolone Acetonide Inhibits p38MAPK Activation and (2013). Isolation and characterization of mouse bone marrow- Neuronal Apoptosis in Early Diabetic Retinopathy. Current derived Lin-/VEGF-R2+ progenitor cells. Annals of Molecular Medicine, 13(6), 946-958. [More href="http://dx.doi.org/10.1007/s00277-013-1815-0">[More Information] Information] 2012 Chung, S., Shen, W., Gillies, M. (2013). Laser Capture Microdissection-Directed Profiling of Glycolytic and mTOR Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, Pathways in Areas of Selectively Ablated Muller Cells in the T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. Murine Retina. Investigative Ophthalmology and Visual (2012). "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia. Investigative The role of glia in retinal vascular disease. Clinical and Ophthalmology and Visual Science, 53(10), 6145-6152. [More href="http://dx.doi.org/10.1111/j.1444- Information] 0938.2012.00741.x">[More Information] Haller, J., Bandello, F., Belfort, R., Gillies, M., Loewenstein, Zhang, X., Chen, M., Gillies, M. (2012). Two Isoforms of Flk-1 A., Yoon, Y., Li, X., Whitcup, S. (2012). Author reply. Transcripts in Early Diabetic Rat Retinas. Current Eye Ophthalmology, 119(12), 2655-2656. [More href="http://dx.doi.org/10.3109/02713683.2011.629766">[More Information] Information] Salem, W., Fraser-Bell, S., Gillies, M. (2012). Clinical Cherepanoff, S., Killingsworth, M., Zhu, M., Nolan, T., development of new treatments for diabetic macular oedema. Hunyor, A., Young, S., Hageman, G., Gillies, M. (2012). Clinical and Experimental , 95(3), 297-305. [More Information] of Ophthalmology, 96(11), 1404-1409. [More Information] J., Lee, S., Coorey, N., Killingsworth, M., Sherman, L., Gillies, M. (2012). Conditional Muller Cell Ablation Causes 2011 Independent Neuronal and Vascular in a Novel Transgenic Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, Model. Journal of Neuroscience, 32(45), 15715-15727. [More Information] macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology, 118(12), McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, 2453-2460. [More Promoting Success and Influencing Complications in Laser- Information] Induced Central Vein Bypass. Ophthalmology, 119(12), 2579- 2586. [More Baroud, G., Gillies, M. (2011). Disadvantages of balloon Information] kyphoplasty with PMMA - A clinical and biomechanical statement. Journal fur Mineralstoffwechsel, 18(Suppl 1), 9-12. Parmalee, N., Schubert, C., Figueroa, M., Bird, A., Peto, T., Gillies, M., Bernstein, P., Kiryluk, K., Terwilliger, J., Irhimeh, M., Shen, W., Chung, S., Zhu, L., Barthelmes, D., Allikmets, R. (2012). Identification of a Potential Susceptibility Gillies, M. (2011). Erythropoetin treatment recruits pECFCs Locus for Macular Telangiectasia Type 2. PloS One, 7(8), 1-10. from the marrow into the blood and stabilizes retinal [More Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Information] Arnold, J., Wong, T. (2011). Intravitreal Triamcinolone Prior to Dabirrahmani, D., Becker, S., Hogg, M., Appleyard, R., Laser Treatment of Diabetic Macular Edema 24-Month Results Baroud, G., Gillies, M. (2012). Mechanical variables affecting of a Randomized Controlled Trial. Ophthalmology, 118(5), 866- balloon kyphoplasty outcome - a finite element study. 872. [More Engineering, 15(3), 211-220. href="http://dx.doi.org/10.1080/10255842.2010.522183">[More Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Information] Fruttiger, M., Gillies, M. (2011). Pilot Application of iTRAQ to Zhu, M., Gillies, M. (2012). New insight of clinical and the Retinal Disease Macular Telangiectasia. Journal of laboratory aspects of macular telangiectasia type 2. 17th Proteome Research, 11(2), 537-553. [More China: Chinese Ophthalmological Society. Information] Len, A., Powner, M., Zhu, L., Hageman, G., Song, X., Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 1. Fruttiger, M., Gillies, M. (2012). Pilot application of iTRAQ to Australian Doctor, 22, 27-32. the retinal disease macular telangiectasia. Journal of Proteome Fraser-Bell, S., Gillies, M. (2011). Retinal conditions - Part 2. Research, 11(2), 537-553. [More Information] Shen, W., Zhang, J., Chung, S., Hu, Y., Ma, Z., Gillies, M. (2011). Submacular DL-alpha-Aminoadipic Acid Eradicates Jay, N., Gillies, M. (2012). Proteomic analysis of ophthalmic Primate Photoreceptors but Does Not Affect Luteal Pigment or disease. Clinical and Experimental Ophthalmology, 40(7), 755- the Retinal Vasculature. Investigative Ophthalmology and 763. [More Information] href="http://dx.doi.org/10.1167/iovs.10-6033">[More Sallo, F., Peto, T., Egan, C., Wolf-Schnurrbusch, U., Clemons, Information] T., Gillies, M., Pauleikhoff, D., Rubin, G., Chew, E., Bird, A. Krilis, M., Zhu, M., Gillies, M. (2011). The relationship (2012). The IS/OS Junction Layer in the Natural History of between Muller Cells and Photoreceptors in Type 2 Idiopathic Type 2 Idiopathic Macular Telangiectasia. Investigative Macular Telangiectasia (MacTel). 43rd Annual Scientific Ophthalmology and Visual Science, 53(12), 7889-7895. [More Ophthalmologists RANZCO 2011, Canberra, ACT, Australia. Information] Shen, W., Li, S., Chung, S., Zhu, L., Stayt, J., Su, T., Couraud, Coorey, N., Shen, W., Chung, S., Zhu, L., Gillies, M. (2012). P., Romero, I., Weksler, B., Gillies, M. (2011). Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated Haller, J., Bandello, F., Belfort, R., Blumenkranz, M., Gillies, with TGF-β1-induced permeability of centrally derived M., Heier, J., Loewenstein, A., Yoon, Y., Jacques, M., Jiao, J., vascular endothelium. European Journal of Cell Biology, 90(4), et al (2010). Randomized, sham-controlled trial of 323-332. [More edema due to retinal vein occlusion. Ophthalmology, 117(6), Information] 1134-1146. [More 2010 Information] Parmalee, N., Schubert, C., Merriam, J., Allikmets, K., Bird, A., Shen, W., Li, S., Chung, S., Gillies, M. (2010). Retinal vascular Gillies, M., Peto, T., Figueroa, M., Friedlander, M., Fruttiger, changes after glial disruption in rats. Journal of Neuroscience M., et al (2010). Analysis of candidate genes for macular Research, 88(7), 1485-1499. [More href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retri Information] eve&db=pubmed&dopt=Abstract&list_uids=21179236">[More McAllister, I., Gillies, M., Smithies, L., Rochtchina, E., Harper, Information] C., Daniell, M., Constable, I., Mitchell, P. (2010). The Central Szental, J., Baird, P., Richardson, A., Amirul Islam, F., Scholl, Retinal Vein Bypass Study: a trial of laser-induced chorioretinal H., Issa, P., Holz, F., Gillies, M., Guymer, R. (2010). Analysis venous anastomosis for central retinal vein occlusion. of glutathione S-transferase Pi isoform (GSTP1) single- Ophthalmology, 117(5), 954-965. [More International Ophthalmology, 30(6), 645-650. href="http://dx.doi.org/10.1007/s10792-010-9374-z">[More Gillies, M., Islam, F., Larsson, J., Pasadhika, S., Gaston, C., Information] Zhu, M., Wong, T. (2010). Triamcinolone-induced cataract in Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, eyes with diabetic macular oedema: 3-year prospective data M., Harrington, M. (2010). Baseline characteristics of from a randomized clinical trial. Clinical and Experimental participants in the natural history study of macular Ophthalmology, 38(6), 605-612. [More Information] href="http://dx.doi.org/10.3109/09286580903450361">[More Information] 2009 Gillies, M. (2010). Bevacizumab in ophthalmology: the Cherepanoff, S., McMenamin, P., Gillies, M., Kettle, E., Sarks, controversy moves forward. Clinical and Experimental S. (2009). Bruch's membrane and choroidal macrophages in Ophthalmology, 38(4), 333-334. [More Information] href="http://dx.doi.org/10.1136/bjo.2009.165563">[More Information] Kuo, C., Gillies, M., McCluskey, P. (2010). Intraocular Triamcinolone for Giant Cell Arteritis? Archives of Gillies, M. (2009). Diabetic macular edema. Ophthalmology, Ophthalmology, 128(12). [More eve&db=pubmed&dopt=Abstract&list_uids=21149801">[More Information] Information] Gillies, M., Zhu, M., Chew, E., Barthelmes, D., Hughes, E., Ali, Powner, M., Gillies, M., Tretiach, M., Scott, A., Guymer, R., H., Holz, F., Scholl, H., Issa, P. (2009). Familial Asymptomatic Hageman, G., Fruttiger, M. (2010). Perifoveal müller cell Macular Telangiectasia Type 2. Ophthalmology, 116(12), 2422- depletion in a case of macular telangiectasia type 2. 2429. [More href="http://dx.doi.org/10.1016/j.ophtha.2010.04.001">[More Information] Information] Gillies, M., Simpson, J., Gaston, C., Hunt, G., Ali, H., Zhu, M., Kuo, C., McCluskey, P., Gillies, M. (2010). Sutter, F. (2009). Five-year results of a randomized trial with Pharmacotherapeutic efficacy of preservative-free intravitreal open-label extension of triamcinolone acetonide for refractory triamcinolone acetonide. Expert Opinion on Pharmacotherapy, diabetic macular edema. Ophthalmology, 116(11), 2182-2187. 11(1), 155-166. [More href="http://dx.doi.org/10.1016/j.ophtha.2009.04.049">[More Information] Information] Gillies, M., McAllister, I., Zhu, M., Wong, W., Louis, D., Gillies, M., Simpson, J., Zhu, M., Hunt, G., Ali, H., Gaston, C. Arnold, J., Wong, T. (2010). Pretreatment with Intravitreal (2009). Intravitreal triamcinolone. Ophthalmology, 116(3), 591. Triamcinolone before Laser for Diabetic Macular Edema: 6- [More Investigative Ophthalmology and Visual Science, 51(5), 2322- Information] 2328. [More Tikellis, G., Gillies, M., Guymer, R., McAllister, I., Shaw, J., Information] Wong, T. (2009). Retinal vascular caliber and macular Dabirrahmani, D., Hogg, M., Kohan, L., Gillies, M. (2010). telangiectasia type 2. Ophthalmology, 116(2), 319-323. [More Institution of Mechanical Engineers. Proceedings. Part H: Information] Journal of Engineering in Medicine, 224(9), 1109-1119. [More diabetic macular edema. International Ophthalmology Clinics, Information] 49(2), 121-134. [More href="http://dx.doi.org/10.1097/IIO.0b013e31819fcce8">[More Information] Information] Clemons, T., Gillies, M., Chew, E., Bird, A., Peto, T., Figueroa, Zhang, X., Bao, B., Hambly, B., Gillies, M. (2009). Vascular M., Harrington, M., MacTel Research Group, T. (2008). The endothelial growth factor-A: A multifunctional molecular National Eye Institute Visual Function Questionnaire in the player in diabetic retinopathy. International Journal of macular telangiectasia (MacTel) project. Investigative Biochemistry and Cell Biology, 41(12), 2368-2371. [More href="http://dx.doi.org/10.1167/iovs.08-1749">[More Information] Information] 2008 Gillies, M. (2008). The role of intravitreal steroids in the management of diabetic retinopathy. In Elia J Duh (Eds.), Fischer, M., Fleischhauer, J., Gillies, M., Sutter, F., Helbig, H., Diabetic Retinopathy, (pp. 435-448). USA: Humana Press. [More defects caused by photoreceptor degeneration by quantitative Information] optical coherence tomography. Investigative Ophthalmology McGimpsey, S., Gillies, M. (2008). Treatment of macular and Visual Science, 49(8), 3617-3621. [More Ophthalmology, 92(3), 436-437. href="http://dx.doi.org/10.1136/bjo.2007.125070">[More Mitchell, P., Gillies, M., Wang, J. (2008). Author reply. Information] Ophthalmology, 11, 214. 2007 Barthelmes, D., Sutter, F., Gillies, M. (2008). Differential optical densities of intraretinal spaces. Investigative Barthelmes, D., Gillies, M., Fleischhauer, J., Sutter, F. (2007). Ophthalmology and Visual Science, 49(8), 3529-3534. [More features of cone dystrophy. Eye, 21(12), 1534-1535. href="http://dx.doi.org/10.1038/sj.eye.6702985">[More Information] Hughes, E., Zhu, M., Barthelmes, D., Ali, H., Issa, P., Gillies, M. (2008). Familial Asymptomatic Macular Telangiectasia Gillies, M., Hogg, M., Kohan, L., Cordingley, R. (2007). Type 2. 40th Annual Scientific Congress of the Royal Adaptive bone remodelling of all polyethylene Australian and New Zealand College of Ophthalmologists unicompartmental tibial bearings. ANZ Journal of Surgery, RANZCO 2008, Melbourne, VIC, Australia. 77(1- 2), 69-72. [More Information] Liew, G., Gillies, M., Wang, J. (2008). Fenofibrate and diabetic retinopathy. The Lancet, 371(9614), 721-721. [More Information] Medical Retina, (pp. 131-146). Germany: Springer. [More Zhang, X., Bao, B., Lai, D., Rapkins, R., Gillies, M. (2008). Information] Intravitreal Triamcinolone Acetonide Inhibits Breakdown of the Blood-Retinal Barrier through Differential Regulation of VEGF- Gillies, M., Amirul Islam, F., Zhu, M., Larsson, J., Wong, T. A and its Receptors in Early Diabetic Rat Retinas. Diabetes, (2007). Efficacy and safety of multiple intravitreal 57(4), 1026-1033. [More Information] oedema. British Journal of Ophthalmology, 91(10), 1323-1326. [More Barthelmes, D., Gillies, M., Sutter, F. (2008). Quantitative OCT Information] analysis of idiopathic perifoveal telangiectasia. Investigative Ophthalmology and Visual Science, 49(5), 2156-2162. [More diabetic retinopathy - A systematic review. JAMA - Journal of Information] the American Medical Association, 298(8), 902-916. [More Larsson, J., Kifley, A., Zhu, M., Wang, J., Mitchell, P., Sutter, Information] F., Gillies, M. (2008). Rapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data Quin, G., Len, A., Billson, F., Gillies, M. (2007). Proteome map from a randomized, placebo-controlled, clinical trial. Acta of normal rat retina and comparison with the proteome of Ophthalmologica, 87(3), 275-280. [More Information] href="http://dx.doi.org/10.1002/pmic.200600486">[More Information] Wickremasinghe, S., Rogers, S., Gillies, M., Zhu, M., Wong, T. (2008). Retinal vascular caliber changes after intravitreal Gillies, M., Wong, T. (2007). Ranibizumab for neovascular age- triamcinolone treatment for diabetic macular edema. related macular degeneration. New England Journal of Investigative Ophthalmology and Visual Science, 49(11), 4707- Medicine, 356(7), 748-750. [More href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retri Information] eve&db=pubmed&dopt=Abstract&list_uids=17310523">[More Information] Sliesoraityte, I., Tikellis, G., Wang, J., Mitchell, P., Gillies, M., Wong, T. (2008). Retinal vessel diameter and diabetic macular Gillies, M., Larsson, J. (2007). The effect of intravitreal edema. Investigative Ophthalmology and Visual Science, on triamcinolone on foveal edema in exudative macular line(May). degeneration. American Journal of Ophthalmology, 144(1), 134- 136. [More 416-417; author reply 417. posterior subcapsular cataract. Ophthalmology, 112(1), 139- 2006 143. [More Zhu, M., Gillies, M., Amirul Islam, F., Larsson, J., Wong, T. Information] (2006). Efficacy and safety of multiple intravitreal Wang, Y., Li, S., Zhu, M., Chen, S., Liu, Y., Men, X., Gillies, triamcinolone injections for refractory diabetic macular M., Larsson, J. (2005). after successful retinal oedema. AOVS Annual Meeting 2006. detachment surgery: an optical coherence tomography study. Sirimaharaj, M., Robinson, M., Zhu, M., Csaky, K., Donovan, Acta Ophthalmologica Scandinavica, 83(2), 168-171. [More Information] 26(5), 578-580. [More Information] between reduction of foveal thickness and visual acuity in Gillies, M., Sutter, F., Simpson, J., Larsson, J., Ali, H., Zhu, M. diabetic macular edema treated with intravitreal triamcinolone. (2006). Intravitreal Triamcinolone for Refractory Diabetic American Journal of Ophthalmology, 139(5), 802-6. [More Placebo-Controlled, Randomized Clinical Trial. Information] Ophthalmology, 113(9), 1533-1538. [More removal of cataract caused by intravitreal triamcinolone in Information] combination with photodynamic therapy for exudative age- Chew, E., Gillies, M., Bird, A. (2006). Macular telangiectasia: a related macular degeneration. Clinical and Experimental simplified classification. Archives of Ophthalmology, 124(4), Ophthalmology, 33(5), 544-5. [More 9071.2005.01082.x">[More Information] Information] 2004 Cherepanoff, S., Mitchell, P., Wang, J., Gillies, M. (2006). Retinal autoantibody profile in early age-related macular Tretiach, M., Madigan, M., Gillies, M. (2004). Conditioned degeneration: preliminary findings from the Blue Mountains Medium From Mixed Retinal Pigmented Epithelium And Eye Study. Clinical and Experimental Ophthalmology, 34(6), M?Ller Cell Cultures Reduces In Vitro Permeability Of Retinal 590-5. [More Information] 88(7), 957-961. [More Gillies, M., Simpson, J., Zhu, M. (2006). Triamcinolone for Information] occult exudative age-related macular degeneration. American Journal of Ophthalmology, 141(1), 228. [More Intravitreal Triamcinolone For Diabetic Macular Edema That Information] Persists After Laser Treatment: Three-Month Efficacy And Safety Results Of A Prospective, Randomized, Double-Masked, Gillies, M. (2006). What we don't know about avastin might Placebo-Controlled Clinical Trial. Ophthalmology, 111(11), hurt us. Archives of Ophthalmology, 124(10), 1478-1479. [More href="http://dx.doi.org/10.1016/j.ophtha.2004.05.025">[More Information] Information] 2005 Gillies, M., Simpson, J., Billson, F., Luo, W., Penfold, P., Chua, W., Mitchell, P., Zhu, M., Hunyor, A. (2004). Safety Of An Gillies, M., Zhu, M., Simpson, J., Sutter, F. (2005). A Intravitreal Injection Of Triamcinolone: Results From A randomized, placebo-controlled trial of intravitreal Randomized Clinical Trial. Archives of Ophthalmology, 122(3), triamcinolone acetonide for diabetic macularedema that persists 336-340. [More Meeting 2005. Information] Zhu, M., Larsson, J., El Jamal, H., Gillies, M. (2005). Correlation between intraocular pressure, visual acuity and 2003 reduction of foveal thickness in diabetic macular oedema Gillies, M., Simpson, J., Luo, W., Penfold, P., Hunyor, A., treated with intravitreal Triamcinolone. ARVO Annual Meeting Chua, W., Mitchell, P., Billson, F. (2003). A randomized 2005. clinical trial of a single dose of intravitreal Triamcinolone Larssor, J., Wong, J., Kifley, A., Mitchell, P., Sutter, F., Zhu, Acetonide for Neovascular age-related macular M., Gillies, M. (2005). Effect of intravitreal Triamcinolone on degeneration;one year results. Archives of Ophthalmology, 121, hard exudates in patients with diabetic retinopathy - a pilot, 667-673. [More 2005. Information] Tretiach, M., Madigan, M., Wen, L., Gillies, M. (2005). Effect Sutter, F., Gillies, M. (2003). Intravitreal triamcinolone for of Müller cell co-culture on in vitro permeability of bovine radiation-induced macular edema. Archives of Ophthalmology, retinal vascular endothelium in normoxic and hypoxic 11, 1491-1492. [More href="http://dx.doi.org/10.1016/j.neulet.2004.12.026">[More Information] Information] Sutter, F., Gillies, M. (2003). Pseudo-endophthalmitis after Gillies, M., Kuzniarz, M., Craig, J., Ball, M., Luo, W., intravitreal injection of triamcinolone. British Journal of Simpson, J. (2005). Intravitreal triamcinolone-induced elevated Ophthalmology, 87(8), 972-974. [More Information] Zhu, M., Gillies, M., Kuzniarz, M., Hunyor, B., Luo, W. (2003). Safety of a second intravitreal injection of triamcinolone. Australian Ophthalmic and Visual Sciences Meeting (Melbourne 2003). Wang, J., Mitchell, P., Smith, W., Gillies, M., Billson, F. (2003). Systemic use of ani-inflammatory medications and age- related maculopathy: The Blue Mountains Eye Study. Ophthalmic Epidemiology, 10(1), 37-48. [More Information] van Reyk, D., Gillies, M., Davies, M. (2003). The retina: oxidative stress and diabetes. Redox Report, 8(4), 187-192. [More Information] Tretiach, M., Van Driel, D., Gillies, M. (2003). Transendothelial electrical resistance of bovine retinal capillary endothelial cells is influenced by cell growth patterns: an ultrastructural study. Clinical and Experimental Ophthalmology, 31(4), 348-353. [More Information] 2001 Penfold, P., Madigan, M., Gillies, M., Provis, J. (2001). Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research, 20, 385- 414.